Role of Iron and Copper in the Pathogenesis of Parkinson's Disease.

about

Role of Iron and Copper in the Pathogenesis of Parkinson's Disease.

Item

http://www.wikidata.org/entity/Q47947787

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Role of Iron and Copper in the Pathogenesis of Parkinson's Disease.

@en

Role of Iron and Copper in the Pathogenesis of Parkinson's Disease.

@nl

type

Item

label

Role of Iron and Copper in the Pathogenesis of Parkinson's Disease.

@en

Role of Iron and Copper in the Pathogenesis of Parkinson's Disease.

@nl

prefLabel

Role of Iron and Copper in the Pathogenesis of Parkinson's Disease.

@en

Role of Iron and Copper in the Pathogenesis of Parkinson's Disease.

@nl

P1476

Role of Iron and Copper in the Pathogenesis of Parkinson's Disease.

@en

P2093

Mohit Kumar Gangania

http://www.w3.org/2001/XMLSchema#string

Rachna Agarwal

http://www.w3.org/2001/XMLSchema#string

Suman Kushwaha

http://www.w3.org/2001/XMLSchema#string

P2860

Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study.

The Haber-Weiss reaction and mechanisms of toxicity.

Assessing plasma levels of selenium, copper, iron and zinc in patients of Parkinson's disease.

The relevance of iron in the pathogenesis of Parkinson's disease.

Novel chelators for central nervous system disorders that involve alterations in the metabolism of iron and other metal ions.

Case-control studies on ceruloplasmin and superoxide dismutase (SOD1) in neurodegenerative diseases: a short review.

Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.

Individual dopaminergic neurons show raised iron levels in Parkinson disease.

Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives.

Altered systemic iron metabolism in Parkinson's disease.

P2888

s12291-016-0614-5

P304

353-356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12291-016-0614-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jyoti Batra

P577

2016-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28811697

http://www.w3.org/2001/XMLSchema#string

P932

5539009

http://www.w3.org/2001/XMLSchema#string